Policy Notices

• Reiterating Organization Eligibility and Application Submission for NIH Research Enhancement Awards (R15)
  (NOT-OD-21-135)
  National Institutes of Health
  

General Notices

• Notice to Extend Eligibility for Submission to PAR-19-371, NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) due to COVID-related Disruptions
  (NOT-AI-21-062)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Pre-Application Webinar for the "Early Detection Research Network" Program: RFA-CA-21-033, RFA-CA-21-034, and RFA-CA-21-035
  (NOT-CA-21-088)
  National Cancer Institute
  

• Notice of Pre-Application Webinar for Non-Human Primate Developmental Genotype-Tissue Expression Project (NHP dGTEx)
  (NOT-HG-21-035)
  National Human Genome Research Institute
  

• NIH Announces the Open Period of FY 2022 Helium-3 Requests for Medical Research
  (NOT-HL-21-016)
  National Heart, Lung, and Blood Institute
  

• Notice of Information: NIMH High-Priority Areas for Research on Women's Mental Health during the Perinatal Period
  (NOT-MH-21-270)
  National Institute of Mental Health
  

• Request for Information (RFI): Inviting Input to Broaden the Benefits of AI/ML Technologies to Reduce Health Disparities and Inequities and Enhance the Diversity of the AI/ML Workforce
  (NOT-OD-21-147)
  National Institutes of Health
  

Notice of Changes to Funding Opportunities

• Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PAR-20-125 Native American Research Centers for Health (NARCH) (S06 Clinical Trials Optional)
  (NOT-AA-21-034)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Correction to the Response Date for NOT-CA-087 "Request for Information on Datasets Collecting Temporally-Linked Diet, Physical Activity, and Sleep Data to Facilitate Integrated Research on 24-Hour Behavior Patterns"
  (NOT-CA-21-089)
  National Cancer Institute
  

• Notice of NIDCR Participation in RFA-CA-21-035 The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
  (NOT-DE-21-005)
  National Institute of Dental and Craniofacial Research
  

• Notice of NIDCR Participation in PAR-21-168, "Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)"
  (NOT-DE-21-006)
  National Institute of Dental and Craniofacial Research
  

• Notice of Change to NOT-NR-19-011: "Notice of NINR's Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)"
  (NOT-NR-21-005)
  National Institute of Nursing Research
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
  (NOT-CA-21-090)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
  (NOT-CA-21-091)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for the NIH HEAL Initiative: Preventing Opioid Misuse and other Drug Use by Intervening on Social Determinants (R01 Clinical Trials Optional)
  (NOT-DA-21-050)
  National Institute on Drug Abuse
  Office of Behavioral and Social Sciences Research
  

• Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional)
  (NOT-NS-21-066)
  National Institute of Neurological Disorders and Stroke
  

Notices of Special Interest

• Notice of Special Interest: Genetics of Alcohol Sensitivity and Tolerance
  (NOT-AA-21-029)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Special Interest: Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease
  (NOT-AG-21-018)
  National Institute on Aging
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

• Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV
  (NOT-AI-21-054)
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide
  (NOT-AI-21-057)
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Mental Health
  

• Notice of Special Interest: Administrative Supplements for Cancer Moonshot awardees and Cancer Center Support Grants (CCSG) to Support Development of an "Immune Radiation Response Index (i-RRI)" for Immune Cells from Normal and Tumor Microenvironments
  (NOT-CA-21-083)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): New Information Technology-Enabled Care Delivery Models to Improve Depression Care in Cancer
  (NOT-CA-21-085)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Advancing HIV/AIDS Research through Computational Neuroscience
  (NOT-DA-21-030)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition
  (NOT-HD-21-027)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  

• Notice of Special Interest (NOSI): Clarification of the Objectives and Program Elements in NHGRI Applications Submitted in Response to the "Ruth L. Kirschstein NRSA Institutional Research Training Grants (Parent T32)"
  (NOT-HG-21-032)
  National Human Genome Research Institute
  

Funding Opportunities

• Patient Safety Learning Laboratories: Advancing Patient Safety through Design, Systems Engineering, and Health Services Research (R18 Clinical Trial Optional)
  (PA-21-266)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is September 25, 2021. All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)
  (PAR-21-249)
  National Eye Institute
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional)
  (PAR-21-250)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
  (PAR-21-275)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed)
  (RFA-AG-22-025)
  National Institute on Aging
  Application Receipt Date(s): October 20, 2021
  
  

• Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)
  (RFA-CA-21-026)
  National Cancer Institute
  Application Receipt Date(s): October 08, 2021
  
  

• Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)
  (RFA-CA-21-027)
  National Cancer Institute
  Application Receipt Date(s): October 08, 2021
  
  

• Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
  (RFA-CA-21-040)
  National Cancer Institute
  Application Receipt Date(s): November 1, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.
  
  

• Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed)
  (RFA-DA-22-003)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 02, 2022
  
  

• Large Scale Mapping and/or Molecular Profiling of Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed)
  (RFA-DA-22-011)
  National Institute on Drug Abuse
  Application Receipt Date(s): October 15, 2021
  
  

• NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional)
  (RFA-DC-22-001)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)
  (RFA-DK-21-021)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): February 17, 2022 and October 7, 2022
  
  

• CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
  (RFA-ES-21-006)
  National Institute of Environmental Health Sciences
  National Eye Institute
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required)
  (RFA-MH-21-240)
  National Institute of Mental Health
  Application Receipt Date(s): November 09, 2021
  
  

• Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required)
  (RFA-MH-21-241)
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): November 09, 2021